Diet
GLP-1 Medications: Conversations and Considerations
The conversation around GLP-1 medications needs to shift.
Posted January 15, 2026 Reviewed by Margaret Foley
Key points
- GLP-1 is a hormone that communicates to the brain whenever fullness is present.
- GLP-1 medications mimic the GLP-1 hormone, resulting in increased feelings of satiety and reduced appetite.
- Prioritizing adequate protein intake along with resistance training is vital for those taking GLP-1s.
The rise in individuals who are prescribed GLP-1 medications has resulted in online discussion and a stigma that is apparent across all media channels. Instead of looking at why these medications are proving to be so effective from a scientific standpoint, many individuals online fuel conversations surrounding controversy and judgment. For example, many celebrities have come under public scrutiny for using GLP-1 medications, with critics claiming that they are “cheating” their way to weight loss.
The increase in scrutiny regarding the use of GLP-1s has become harmful to the public’s general understanding and perception of these medications. GLP-1 medications were created to target the treatment of Type 2 diabetes in an effort to promote improved blood sugar management. While this medication has proven to be effective for the management of diabetes, later findings revealed that GLP-1s can also be effective in targeting weight management. Presently, GLP-1 medications are approved for use in the treatment management of both Type 2 diabetes and obesity.
To understand how GLP-1 medications can promote weight loss, it is important to learn how they work in the body. Naturally within the body, GLP-1 is a hormone that communicates to the brain whenever fullness is present, which helps with food intake regulation. The GLP-1 hormone also delays gastric emptying, meaning it slows down how quickly food leaves the stomach. Whenever the GLP-1 medication is used, it mimics the GLP-1 hormone in the body, resulting in increased feelings of satiety along with a reduction in appetite. With these two roles considered, it is no surprise that individuals who are using GLP-1 medications report a decrease in appetite and a reduction in overall food intake.
While GLP-1s tend to be both praised and criticized by segments of the public, many individuals don’t understand that being on the medication alone does not guarantee long-term weight loss and improved health outcomes. Being on the medication requires a change in behavior and nutritional habits. Individuals who are taking GLP-1 medications have to prioritize adequate protein intake to preserve lean muscle mass while simultaneously incorporating resistance training. It is a misconception that protein alone will preserve muscle when losing weight. While protein is essential, maintaining muscle mass also requires strength-based training exercises. Individuals taking GLPs often also struggle to maintain adequate hydration.
It is important to note that being on the medication carries potential side effects. Many individuals on GLP-1 medications experience gastrointestinal-related side effects. These side effects include, but are not limited to, nausea, diarrhea, vomiting, constipation, and abdominal distention. Fortunately, side effects do improve for many individuals as their body adapts to the physiological mechanisms of the medication.
Ultimately, the conversation regarding GLP-1s needs to change. GLP-1 medications are not an immediate, quick fix for chronic health conditions like obesity; however, they do provide a meaningful therapeutic option that supports the body’s natural biological pathways. Being prescribed a GLP-1 medication does not constitute failure; it reflects an evidence-based approach to managing a complex, multifactorial chronic health condition. It is time to move beyond judgment and shift the conversation about GLPs toward one that reflects science-based research and compassion.
